Noramco Group Invests $25M in Sterile Injectable Expansion
The Noramco Group, an integrated North American-based API and drug product supply chain product and services provider, announced a $25 million investment in its Halo Pharma facility in Whippany, New Jersey, to establish sterile injectable manufacturing capabilities, including ready-to-use syringe, cartridge, and vial …
